title: Favorable prognostic impact of RAS mutation status in multiple myeloma treated with high-dose melphalan and autologous stem cell support in the era of novel agents: a single center perspective.
authors.affiliation: a Department of Internal Medicine I , University Hospital of Schleswig-Holstein , Luebeck , Germany.
authors.forename: Niklas
authors.initials: N
authors.lastname: Gebauer
authors.affiliation: a Department of Internal Medicine I , University Hospital of Schleswig-Holstein , Luebeck , Germany.
authors.forename: Harald
authors.initials: H
authors.lastname: Biersack
authors.affiliation: b Department of Pathology , Reference Centre for Lymph Node Pathology and Hematopathology, University Hospital of Schleswig-Holstein , Luebeck , Germany.
authors.forename: Ann-Cathrin
authors.initials: AC
authors.lastname: Czerwinska
authors.affiliation: b Department of Pathology , Reference Centre for Lymph Node Pathology and Hematopathology, University Hospital of Schleswig-Holstein , Luebeck , Germany.
authors.forename: Janina
authors.initials: J
authors.lastname: Schemme
authors.affiliation: a Department of Internal Medicine I , University Hospital of Schleswig-Holstein , Luebeck , Germany.
authors.forename: Tim Tristan
authors.initials: TT
authors.lastname: Hardel
authors.affiliation: b Department of Pathology , Reference Centre for Lymph Node Pathology and Hematopathology, University Hospital of Schleswig-Holstein , Luebeck , Germany.
authors.forename: Veronica
authors.initials: V
authors.lastname: Bernard
authors.affiliation: c Department of Radiation Oncology , University Hospital of Schleswig-Holstein , Luebeck , Germany.
authors.forename: Dirk
authors.initials: D
authors.lastname: Rades
authors.affiliation: a Department of Internal Medicine I , University Hospital of Schleswig-Holstein , Luebeck , Germany.
authors.forename: Hendrik
authors.initials: H
authors.lastname: Lehnert
authors.affiliation: a Department of Internal Medicine I , University Hospital of Schleswig-Holstein , Luebeck , Germany.
authors.forename: Kim Barbara
authors.initials: KB
authors.lastname: Luley
authors.affiliation: b Department of Pathology , Reference Centre for Lymph Node Pathology and Hematopathology, University Hospital of Schleswig-Holstein , Luebeck , Germany.
authors.forename: Christoph
authors.initials: C
authors.lastname: Thorns
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage*; D011905:Genes, ras; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D053208:Kaplan-Meier Estimate; D008558:Melphalan / Q000008:administration & dosage*; D009101:Multiple Myeloma / Q000235:genetics* / Q000401:mortality / Q000628:therapy*; D009154:Mutation; D011379:Prognosis; D019172:Transplantation Conditioning; D014182:Transplantation, Autologous; D016896:Treatment Outcome
chemical_list: D018906:Antineoplastic Agents, Alkylating; D008558:Melphalan